首页> 外文期刊>The journal of obstetrics and gynaecology research >Outcomes of uterine cervical cancer patients with pelvic lymph node metastases after radiotherapy without boost irradiation of metastases
【24h】

Outcomes of uterine cervical cancer patients with pelvic lymph node metastases after radiotherapy without boost irradiation of metastases

机译:放射治疗后盆腔淋巴结转移的子宫宫颈癌患者的结果而无升压转移辐射

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Aim The aim of this study was to evaluate the outcomes of uterine cervical cancer patients with pelvic lymph node (PLN) metastases after radiotherapy without boost irradiation of the metastases and to clarify the necessity of the boost irradiation of metastatic lesions. Methods Thirty‐two patients with uterine cervical cancer metastasizing only to the PLN were treated with definitive radiotherapy without boost irradiation of the metastases between 2008 and 2012 at our institution and were selected for this study. The pattern of progression, overall survival, and progression‐free survival were analyzed. Results Ninety percent of the PLN metastases were controlled by radiotherapy. Twenty‐two of 32 patients (69%) experienced progression. Distant metastases as initial progression were observed in 21 of these 22 patients (95%). Only two patients experienced failures in pre‐treatment metastatic PLN as initial progression, along with other failures. Severe late lower gastrointestinal toxicities were not observed in any patients. Two‐year cumulative overall survival and progression‐free survival were 74% and 31%, respectively. Conclusion Boost irradiation of PLN metastases is not necessarily indispensable. Further studies to examine the necessity of boost irradiation of PLN metastases in radiotherapy for uterine cervical cancer patients with metastases are required.
机译:摘要目的本研究的目的是在放射治疗后评估子宫宫颈癌患者的骨盆淋巴结(PLN)转移的结果,而不会提高转移照射并阐明转移性病变的增压照射的必要性。方法采用明确的放疗治疗三十二个患有子宫宫颈癌转移的患者,未经明确放疗,无需在我们的机构促进2008年至2012年期间转移的辐射。分析了进展的模式,整体存活和无进展生存期。结果通过放射疗法控制百分之九十的PLN转移。 22例患者中的22例(69%)经历了进展。在这22名患者中的21例(95%)中观察到远处转移作为初始进展。只有两名患者在预处理转移PLN中经历了失败,作为初始进展,以及其他故障。在任何患者中未观察到严重的晚期胃肠道毒性。两年累积的整体存活和无进展生存率分别为74%和31%。结论PLN转移辐照不一定是不可或缺的。需要进一步研究,以研究各种宫颈癌患者的放射治疗PLN转移辐射的必要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号